These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 31061163

  • 1. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
    Zandi K, Bassit L, Amblard F, Cox BD, Hassandarvish P, Moghaddam E, Yueh A, Libanio Rodrigues GO, Passos I, Costa VV, AbuBakar S, Zhou L, Kohler J, Teixeira MM, Schinazi RF.
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061163
    [Abstract] [Full Text] [Related]

  • 2. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
    Chen YL, Yokokawa F, Shi PY.
    Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
    Lee JC, Tseng CK, Wu YH, Kaushik-Basu N, Lin CK, Chen WC, Wu HN.
    Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
    [Abstract] [Full Text] [Related]

  • 4. Betulinic acid exhibits antiviral effects against dengue virus infection.
    Loe MWC, Hao E, Chen M, Li C, Lee RCH, Zhu IXY, Teo ZY, Chin WX, Hou X, Deng J, Chu JJH.
    Antiviral Res; 2020 Dec; 184():104954. PubMed ID: 33080251
    [Abstract] [Full Text] [Related]

  • 5. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
    Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.
    Virol J; 2011 Dec 28; 8():560. PubMed ID: 22201648
    [Abstract] [Full Text] [Related]

  • 6. Anti-flavivirus activity of polyoxometalate.
    Qi Y, Han L, Qi Y, Jin X, Zhang B, Niu J, Zhong J, Xu Y.
    Antiviral Res; 2020 Jul 28; 179():104813. PubMed ID: 32376449
    [Abstract] [Full Text] [Related]

  • 7. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
    Quintana VM, Selisko B, Brunetti JE, Eydoux C, Guillemot JC, Canard B, Damonte EB, Julander JG, Castilla V.
    Antiviral Res; 2020 Apr 28; 176():104749. PubMed ID: 32081740
    [Abstract] [Full Text] [Related]

  • 8. Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral Activity.
    Hour MJ, Chen Y, Lin CS, Baltina LA, Kan JY, Tsai YT, Kiu YT, Lai HC, Baltina LA, Petrova SF, Lin CW.
    Int J Mol Sci; 2022 Sep 07; 23(18):. PubMed ID: 36142222
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of dengue virus by an ester prodrug of an adenosine analog.
    Chen YL, Yin Z, Lakshminarayana SB, Qing M, Schul W, Duraiswamy J, Kondreddi RR, Goh A, Xu HY, Yip A, Liu B, Weaver M, Dartois V, Keller TH, Shi PY.
    Antimicrob Agents Chemother; 2010 Aug 07; 54(8):3255-61. PubMed ID: 20516277
    [Abstract] [Full Text] [Related]

  • 10. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
    Lee E, Pavy M, Young N, Freeman C, Lobigs M.
    Antiviral Res; 2006 Jan 07; 69(1):31-8. PubMed ID: 16309754
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
    Pelliccia S, Wu YH, Coluccia A, La Regina G, Tseng CK, Famiglini V, Masci D, Hiscott J, Lee JC, Silvestri R.
    J Enzyme Inhib Med Chem; 2017 Dec 07; 32(1):1091-1101. PubMed ID: 28776445
    [Abstract] [Full Text] [Related]

  • 12. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
    Kuo YT, Liu CH, Li JW, Lin CJ, Jassey A, Wu HN, Perng GC, Yen MH, Lin LT.
    Sci Rep; 2020 Oct 02; 10(1):16378. PubMed ID: 33009425
    [Abstract] [Full Text] [Related]

  • 13. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
    Panya A, Songprakhon P, Panwong S, Jantakee K, Kaewkod T, Tragoolpua Y, Sawasdee N, Lee VS, Nimmanpipug P, Yenchitsomanus PT.
    Molecules; 2021 May 23; 26(11):. PubMed ID: 34071102
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
    Wang QY, Bushell S, Qing M, Xu HY, Bonavia A, Nunes S, Zhou J, Poh MK, Florez de Sessions P, Niyomrattanakit P, Dong H, Hoffmaster K, Goh A, Nilar S, Schul W, Jones S, Kramer L, Compton T, Shi PY.
    J Virol; 2011 Jul 23; 85(13):6548-56. PubMed ID: 21507975
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.
    Abdul Ahmad SA, Palanisamy UD, Khoo JJ, Dhanoa A, Syed Hassan S.
    Virol J; 2019 Feb 27; 16(1):26. PubMed ID: 30813954
    [Abstract] [Full Text] [Related]

  • 16. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis.
    Lu CY, Chang YC, Hua CH, Chuang C, Huang SH, Kung SH, Hour MJ, Lin CW.
    Int J Mol Sci; 2017 May 01; 18(5):. PubMed ID: 28468311
    [Abstract] [Full Text] [Related]

  • 17. Antiviral Role of Phenolic Compounds against Dengue Virus: A Review.
    Loaiza-Cano V, Monsalve-Escudero LM, Filho CDSMB, Martinez-Gutierrez M, Sousa DP.
    Biomolecules; 2020 Dec 24; 11(1):. PubMed ID: 33374457
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I, Geluykens P, Clynhens M, Strijbos R, Goethals O, Megens S, Verheyen N, Last S, McGowan D, Coesemans E, De Boeck B, Stoops B, Devogelaere B, Pauwels F, Vandyck K, Berke JM, Raboisson P, Simmen K, Lory P, Van Loock M.
    Antiviral Res; 2017 Nov 24; 147():149-158. PubMed ID: 29037976
    [Abstract] [Full Text] [Related]

  • 19. Antiviral activity of baicalein and quercetin against the Japanese encephalitis virus.
    Johari J, Kianmehr A, Mustafa MR, Abubakar S, Zandi K.
    Int J Mol Sci; 2012 Dec 07; 13(12):16785-95. PubMed ID: 23222683
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests.
    Johnson BW, Kosoy O, Hunsperger E, Beltran M, Delorey M, Guirakhoo F, Monath T.
    Clin Vaccine Immunol; 2009 Jul 07; 16(7):1052-9. PubMed ID: 19458204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.